MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight ... personalized peptide-based therapies. Whether you're exploring Semaglutide tablets ...

They’ve all been used to describe effects of the rapid weight loss that can come from taking glucagon-like peptide-1 receptor agonists like semaglutide, which is in Ozempic. But such weight loss ...

However, emerging research suggests that glucagon-like peptide-1 (GLP-1 ... for Moderation and Abstinence Goals GLP-1 receptor agonists like semaglutide and tirzepatide represent an exciting ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and ...

Canada Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with ...

establishes Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg as the most broadly indicated glucagon-like peptide-1 receptor agonist (GLP-1 RA) in its class. Experience the full interactive ...